These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 32674730)

  • 1. Gene Therapy, A Novel Therapeutic Tool for Neurological Disorders: Current Progress, Challenges and Future Prospective.
    Iqubal A; Iqubal MK; Khan A; Ali J; Baboota S; Haque SE
    Curr Gene Ther; 2020; 20(3):184-194. PubMed ID: 32674730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gene Therapy, A Potential Therapeutic Tool for Neurological and Neuropsychiatric Disorders: Applications, Challenges and Future Perspective.
    Mani S; Jindal D; Singh M
    Curr Gene Ther; 2023; 23(1):20-40. PubMed ID: 35345999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extracellular vesicle and CRISPR gene therapy: Current applications in Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease.
    Akyuz E; Aslan FS; Gokce E; Ilmaz O; Topcu F; Kakac S
    Eur J Neurosci; 2024 Oct; 60(8):6057-6090. PubMed ID: 39297377
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy for neurological disorders: challenges and recent advancements.
    Pena SA; Iyengar R; Eshraghi RS; Bencie N; Mittal J; Aljohani A; Mittal R; Eshraghi AA
    J Drug Target; 2020 Feb; 28(2):111-128. PubMed ID: 31195838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applications of lentiviral vectors for biology and gene therapy of neurological disorders.
    Lundberg C; Björklund T; Carlsson T; Jakobsson J; Hantraye P; Déglon N; Kirik D
    Curr Gene Ther; 2008 Dec; 8(6):461-73. PubMed ID: 19075629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene therapy for neurological disorders.
    Choong CJ; Baba K; Mochizuki H
    Expert Opin Biol Ther; 2016; 16(2):143-59. PubMed ID: 26642082
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-Viral Vector-Mediated Gene Therapy for ALS: Challenges and Future Perspectives.
    Ediriweera GR; Chen L; Yerbury JJ; Thurecht KJ; Vine KL
    Mol Pharm; 2021 Jun; 18(6):2142-2160. PubMed ID: 34010004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lentivirus-mediated gene transfer to the central nervous system: therapeutic and research applications.
    Wong LF; Goodhead L; Prat C; Mitrophanous KA; Kingsman SM; Mazarakis ND
    Hum Gene Ther; 2006 Jan; 17(1):1-9. PubMed ID: 16409120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Delivery for Neurodegenerative Disorders Using Gene Therapy Vectors: Gene Next Therapeutic Goals.
    Singh M; Singh SP; Yadav D; Agarwal M; Agarwal S; Agarwal V; Swargiary G; Srivastava S; Tyagi S; Kaur R; Mani S
    Curr Gene Ther; 2021; 21(1):23-42. PubMed ID: 32811395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delivering Hematopoietic Stem Cell Gene Therapy Treatments for Neurological Lysosomal Diseases.
    Holley RJ; Wood SR; Bigger BW
    ACS Chem Neurosci; 2019 Jan; 10(1):18-20. PubMed ID: 30136572
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNAi: a potential new class of therapeutic for human genetic disease.
    Seyhan AA
    Hum Genet; 2011 Nov; 130(5):583-605. PubMed ID: 21537948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic potential of human adipose-derived stem cells in neurological disorders.
    Chang KA; Lee JH; Suh YH
    J Pharmacol Sci; 2014; 126(4):293-301. PubMed ID: 25409785
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Large animal models of neurological disorders for gene therapy.
    Gagliardi C; Bunnell BA
    ILAR J; 2009; 50(2):128-43. PubMed ID: 19293458
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic therapy for the nervous system.
    Bowers WJ; Breakefield XO; Sena-Esteves M
    Hum Mol Genet; 2011 Apr; 20(R1):R28-41. PubMed ID: 21429918
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring the Role of Gene Therapy for Neurological Disorders.
    Puranik N; Yadav D; Chauhan PS; Kwak M; Jin JO
    Curr Gene Ther; 2021; 21(1):11-22. PubMed ID: 32940177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent gene therapy advancements for neurological diseases.
    Nagabhushan Kalburgi S; Khan NN; Gray SJ
    Discov Med; 2013 Feb; 15(81):111-9. PubMed ID: 23449113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNAs and Neurodegenerative Diseases.
    Qiu L; Tan EK; Zeng L
    Adv Exp Med Biol; 2015; 888():85-105. PubMed ID: 26663180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and applications of non-HIV-based lentiviral vectors in neurological disorders.
    Valori CF; Ning K; Wyles M; Azzouz M
    Curr Gene Ther; 2008 Dec; 8(6):406-18. PubMed ID: 19075624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of CRISPR-Cas9 in Alzheimer's Disease and Related Disorders.
    De Plano LM; Calabrese G; Conoci S; Guglielmino SPP; Oddo S; Caccamo A
    Int J Mol Sci; 2022 Aug; 23(15):. PubMed ID: 35955847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRISPR-Cas9-Mediated Gene Therapy in Neurological Disorders.
    Guan L; Han Y; Yang C; Lu S; Du J; Li H; Lin J
    Mol Neurobiol; 2022 Feb; 59(2):968-982. PubMed ID: 34813019
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.